The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Targeting glioma-initiating cells in GBM: ABTC-0904, a randomized phase 0/II study targeting the Sonic Hedgehog-signaling pathway.
Andrew E. Sloan
No relevant relationships to disclose
Charles John Nock
No relevant relationships to disclose
Xiaobu Ye
No relevant relationships to disclose
Amber Kerstetter
No relevant relationships to disclose
Jeff Supko
No relevant relationships to disclose
Kathleen Lamborn
No relevant relationships to disclose
Jeremy N. Rich
No relevant relationships to disclose
Robert Miller
No relevant relationships to disclose
Naoko Takebe
No relevant relationships to disclose
Michael Prados
No relevant relationships to disclose
Stuart A. Grossman
No relevant relationships to disclose